Nifty 50 stocks: ET Analysis: Stocks excluded from Nifty 50 outperform those included

Nifty 50 stocks: ET Analysis: Stocks excluded from Nifty 50 outperform those included

ET Intelligence Group : Next time the benchmark Nifty 50 index is reconstituted at the end of September, one is likely to gain more by investing in the stock that is being excluded instead of the one that is being included in the index. Two out of three times over the past 10 years, the … Read more

icici bank shares: Hot stocks: Brokerage view on SBI Cards, IndusInd Bank and ICICI Bank

icici bank shares: Hot stocks: Brokerage view on SBI Cards, IndusInd Bank and ICICI Bank

Brokerage firm UBS has a sell view on SBI Cards, Nomura has a neutral rating on IndusInd Bank. Meanwhile, Morgan Stanley and Macquarie have an overweight and outperform rating respectively on ICICI Bank. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: UBS on SBI Cards: Sell| Target … Read more

Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan Company

Hot Stocks: Brokerages view on Aurobindo Pharma, Apollo Hospitals, Suzlon & Titan Company

Brokerage Macquarie maintained an outperform rating on Aurobindo Pharma, Morgan Stanley initiated coverage on Suzlon, CLSA upgraded Apollo Hospital and CLSA maintained a buy rating on Titan Company. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Aurobindo Pharma: Outperform | Target Rs 1,385Macquarie maintained an … Read more

stock recommendations: Hot Stocks: Brokerages on Escorts & SBI; CLSA downgrades Sula

stock recommendations: Hot Stocks: Brokerages on Escorts & SBI; CLSA downgrades Sula

Brokerage JPMorgan maintained an overweight rating on SBI and Macquarie upgraded Escorts to outperform. CLSA downgraded Sula to underperform while maintaining a sell on Asian Paints post Q4 results. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: JPMorgan on SBI: Overweight| Target Rs 1000 JPMorgan maintained an … Read more